Evaluation of inflammatory and biochemical markers in COVID-19 patients treated with tocilizumab alone or with the combination of tocilizumab and convalescent plasma transfusion. Ann Med Res . 2022;29(7):770-776. Accessed April 4, 2025. http://annalsmedres.org/index.php/aomr/article/view/4231